)
)11.3.14
1.3.14
Invasive Micropapillary Carcinoma of the Breast
Definition
- Breast carcinoma with a prominent (pseudo) micropapillary pattern
 
Diagnostic Criteria
- Numerous small pseudo-papillary clusters of cells
- No fibrovascular cores
 - Frequent central lumen formation in clusters
 - Peripherally located nuclei frequently bulge out with knobby appearance, "the hedgehog" tumor
 
 - Clusters surrounded by clear spaces
- One or only a few clusters per space
 - Scant mucin rarely detectable in spaces
 
 - Spaces surrounded by loose fibrocollagenous stroma
 - Frequent high nuclear grade reported in some series
 - Frequently has abundant eosinophilic cytoplasm
 - Frequent lymphatic involvement
 - Occasional psammoma bodies
 - Associated DCIS may be of various types
- Not related to micropapillary DCIS
 
 - Pattern may be predominant or focal
- No clinical difference between predominant and focal cases
 - No reported cutoff for minimal significant amount of pattern
 - Report such cases as mixed
 
 - Frequently mixed with infiltrating ductal carcinoma
 - Rarely mixed with other type
 
Clinical
- Incidence
- Pure about 1%
 - Mixed about 4-7%
 
 - Frequent local recurrence (70-90%)
 - Poor prognosis
- Approximate 40% dead of disease in three years
 - Not independent of stage
- Linked to high incidence of nodal involvement
 
 
 - Rare cases reported in males
 
Grading / Staging / Report
Grading
- Bloom-Scarff-Richardson grading scheme is most widely used
 - Total score and each of the three components should be reported
 - Based on invasive area only
 
| Tubule formation | Score | 
|---|---|
| >75% tubules | 1 | 
| 10-75% tubules | 2 | 
| <10 span="" tubules="">10> | 3 | 
| Nuclear pleomorphism (most anaplastic area) | Score | 
|---|---|
| Small, regular, uniform nuclei, uniform chromatin | 1 | 
| Moderate varibility in size and shape, vesicular, with visible nucleoli | 2 | 
| Marked variation, vesicular, often with multiple nucleoli | 3 | 
| Mitotic figure count per 10 40x fields (depends on area of field, see key below) | Score | ||||
|---|---|---|---|---|---|
| 0.096 mm2 | 0.12 mm2 | 0.16 mm2 | 0.27 mm2 | 0.31 mm2 | |
| 0-3 | 0-4 | 0-5 | 0-9 | 0-11 | 1 | 
| 4-7 | 5-8 | 6-10 | 10-19 | 12-22 | 2 | 
| >7 | >8 | >10 | >19 | >22 | 3 | 
- Olympus BX50, BX40 or BH2 or AO or Nikon with 15x eyepiece: 0.096 mm2
 - AO with 10x eyepiece: 0.12 mm2
 - Nikon or Olympus with 10x eyepiece: 0.16 mm2
 - Leitz Ortholux: 0.27 mm2
 - Leitz Diaplan: 0.31 mm2
 - Mitotic count figures based on original data presented for Leitz Ortholux by Elston and Ellis 1991, with modifications based on pubished and measured areas of view
 - Evaluate regions of most active growth, usually in cellular areas at periphery
 - We employ strict criteria for identification of mitotic figures
 
| Sum of above three components | Overall grade | 
|---|---|
| 3-5 points | Grade I (well differentiated) | 
| 6-7 points | Grade II (moderately differentiated) | 
| 8-9 points | Grade III (poorly differentiated) | 
Staging
- Micropapillary carcinoma is associated with frequent lymph node metastases
- Seen even with primary tumors <1 cm="" span="">1>
 - Seen even with mixed tumors with small micropapillary component
 - Nodal involvement is frequently by micrometastases
 
 
- TNM staging is the most widely used scheme for breast carcinomas but is not universally employed
 - Critical staging criteria for regional lymph nodes
- Isolated tumor cell clusters
- Usually identified by immunohistochemistry
- Term also applies if cells identified by close examination of H&E stain
 
 - No cluster may be greater than 0.2 mm
 - Multiple such clusters may be present in the same or other nodes
 
 - Usually identified by immunohistochemistry
 - Micrometastasis
- Greater than 0.2 mm, none greater than 2.0 mm
 
 - Metastasis
- At least one carcinoma focus over 2.0 mm
- If one node qualifies as >2.0 mm, count all other nodes even with smaller foci as involved
 
 - Critical numbers of involved nodes: 1-3, 4-9 and 10 and over
 
 - At least one carcinoma focus over 2.0 mm
 - Note extranodal extension
 
 - Isolated tumor cell clusters
 
Report
- Excisions: the following are important elements that must be addressed in the report for infiltrative breast carcinomas
- Grade
- Total score and individual components
 
 - Size of neoplasm
- Give 3 dimensions or greatest dimension
 - Critical cutoffs occur at 0.5 cm and at 2 cm
 
 - Margins of resection
- Measure and report the actual distance of both invasive and in situ carcinoma
 
 - Angiolymphatic invasion
- Indicate if confined to tumor mass, outside tumor mass or in dermis
 
 - (Extensive DCIS is not currently felt to be a significant predictor of behavior)
 - Results of special studies performed for diagnosis
 - Results of prognostic special studies performed
- ER, PR, Proliferation marker, Her2neu
 - If studies were performed on a prior specimen, refer to that report and give results
 
 
 - Grade
 - Needle or core biopsies
- Provisional grade may be given but may defer to excision for definitive grade
 - Presence of absence of angiolymphatic invasion
 - Results of special studies performed for diagnosis
 - Results of prognostic special studies if performed
- ER, PR, Proliferation marker, Her2neu
 - State if studies are deferred for a later excision specimen
 
 
 - Regional lymph nodes
 - Report findings as described above
 
Subscribe to:
Comments (Atom)
List of all the posts
- a common misdiagnosis. (2)
 - ASAP in prostate needle biopsy. (1)
 - breast (3)
 - Breast Biopsy Procedure (3)
 - breast cancer (2)
 - Breast Carcinoma vs. Pulmonary Adenocarcinoma (2)
 - carcinoma (2)
 - core boiopsy. (1)
 - Desmoplastic melanoma (1)
 - Dysplasia in Inflammatory Bowel Disease (1)
 - Errors in Surgical Pathology (1)
 - False positive diagnosis in breast FNAC. (1)
 - FNAC (1)
 - Guidelines for Radical Prostatectomy Surgical Specimen Handling (1)
 - High Grade Prostatic Intraepithelial Neoplasia (HGPIN) (1)
 - Immunohistochemistry in Follicular lymphoid lesions. (1)
 - Immunopheotype of Gastrointestinal stromal tumours (GIST) (1)
 - Importance of Tissue fixation in Cancer management (1)
 - Introduction (1)
 - lymph node biopsy (1)
 - lymphoma (1)
 - Making Sure Your Lab Reports Are Easy to Understand (1)
 - Measuring size of DCIS (1)
 - Microcystic adenocarcinoma of the prostate-pseudobenign carcinoma (1)
 - micropapillary (1)
 - Mimics of Prostate cancer (1)
 - Molecular Cancer Pathology Update (1)
 - Papillary Thyroid Ca Criteria (1)
 - poor prognosis (1)
 - Protocol for Synpotic reporting of Breast excision specimen with diagnosis of Ductal Carcinoma In Situ (DCIS) of the Breast (1)
 - Quality Management Requirements for HER2/neu Marker in Breast Cancer (1)
 - Quirke's Method For Dissecting Colorectal Adenocarcinoma (1)
 - Reporting parameters for positive prostate needle biopsy (1)
 - Research (1)
 - Sentinel Lymph Node Biopsy -Malignant Melanoma (1)
 - Sentinel Lymph Node Mapping-Pathology Protocol in Breast Cancer (1)
 - Synoptic reporting of cancer (1)
 - Updates on Molecular Cancer pathology (1)
 - Work up of Carcinoma of Unknown Primary (CUP) (1)
 


